DOI: 10.1055/s-00000069

Seminars in Liver Disease

Referenz

Hsu C-H, Yang T-S, Hsu C , et al.
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.

Br J Cancer 2010;
102 (6) 981-986

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: